what is the glp 1 drug GLP-1 Medications – Community Education GLP-1 Agonists - What is
Description
Association of antidiabetic medications targeting the glucagon-like peptide 1 pathway and heart failure events in patients with diabetes
Exenatide efficacy and safety: a systematic review
It is known that the CV protection effect of GLP-1RAs have been proven through eight large-scale clinical studies, including Evaluation of LIXisenatide in Acute coronary syndrome (ELIXA) [66], LEADER [44], Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN)-6 [67], Exenatide Study of Cardiovascular Event Lowering (EXSCEL) [68], Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes) [69], Researching Cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) [70], Peptide Innovation for Early Diabetes Treatment (PIONEER) 6 [67,71], and AMPLITUDE-O [51]
Pediatric Type 2 Diabetes: Signs, Treatments, and Prevention Diabetes Drug Ozempic Approved for Weight Loss
CNS Drugs (2019) 33(3):20923
GLP-1 agonists are medications that mimic the action of this hormone
